Abstract: A control device for a vehicle including an operation unit that receives an operation for setting ON or OFF of a plurality of driver assistance functions, wherein at least two or more driver assistance functions among the plurality of driver assistance functions are driver assistance functions classified into a specific group in which the degree of intervention of control for the driving operation is smaller than other driver assistance functions, and the operation unit includes a main switch for collectively setting ON or OFF of the driver assistance functions classified into the specific group.

Abstract: A motor controller includes a plurality of inverters that supply power to a corresponding motor of a plurality of motors through pulse width modulation control, a direct current power supply that supplies power to the plurality of inverters, and a capacitor connected parallel to the direct current power supply. Each of the plurality of inverters is categorized into one of a plurality of groups based on a switching frequency. All inverters in each of the groups have corresponding carrier signals being triangular wave signals determined based on a reference frequency assigned to the group. At least one of the triangular wave signals has at least one of a frequency or a phase different from a frequency or a phase of another triangular wave signal of the triangular wave signals.

Abstract: A DC power supply device capable of preventing voltage oscillation of a power supply path to a motor control device is provided. The DC power supply device includes a power supply unit (such as an AC/DC converter) that outputs a DC and a filter circuit that detects a voltage fluctuation of the DC output from the power supply unit and adjusts impedance of own circuit such that the voltage fluctuation of the DC is prevented based on a detection result.

Abstract: A design assist device assists with designing of a power supply system to supply and distribute power from a power supply and a capacitor connected parallel to each other to a plurality of load devices through a power supply path combining a plurality of power cables. The design assist device includes a calculator and an outputter. The calculator calculates time-series data about a current flowing through the capacitor based on configuration information representing an overall configuration of the power supply path and operation pattern information representing an operation pattern of each of the plurality of load devices, and calculates, based on the time-series data about the current, a recommended capacitance being a capacitance recommended for the capacitor. The outputter outputs at least information about the recommended capacitance for the capacitor.

Abstract: Provided is a gene expression reinforcement system for a recombinant bagworm fibroin H chain protein. The system includes a gene encoding a modified recombinant bagworm fibroin H chain protein in which either the N-terminal domain or the C-terminal domain constituting the recombinant bagworm fibroin H chain protein has been partially or entirely deleted.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: According to one embodiment, there is provided a second block that is connectable via an interface cable to a first block serving as a signal source, and supplies a high-resolution display with image data of a high resolution. The second block has an information transmitter for transmitting particular resolution information different from the high resolution when the resolution information of the high-resolution display is transmitted to the first block. The second block also has an image decoder for decoding, into image data of the high resolution, the image data processed based on the particular resolution information and sent from the first block. The decoded high-resolution image data is output to the high-resolution display.

Abstract: The present invention provides a low molecular weight compound having EPO production-promoting action and/or hemoglobin production-promoting action. The present invention relates to a fused piperidine compound represented by the following general formula (1): (wherein, ring A represents a C10-14 aryl group or 5- to 10-membered heterocyclic group, X represents N—R7, a sulfur atom or an oxygen atom, R1, R2, R2?, R3 and R3? independently represent a hydrogen atom, C1-6 alkyl group or C3-6 cycloalkyl group, and R4, R5 and R6 independently represent a hydrogen atom or halogen atom), or a salt thereof, or a solvate thereof.

Abstract: To provide a novel JAK3 inhibitor that is useful as a preventive and/or therapeutic agent for rejection and graft versus host disease (GvHD) in organ transplantation, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, Sjögren syndrome, Behcet's disease, type I diabetes mellitus, autoimmune thyroiditis, idiopathic thrombocytopenic purpura, ulcerative colitis, Crohn's disease, asthma, allergic rhinitis, atopic dermatitis, contact dermatitis, urticaria, eczema, psoriasis, allergic conjunctivitis, uveitis, cancer, leukemia and the like. The pyridine-3-carboxyamide derivative represented by the general formula (1): or its salt or a solvate thereof.

Abstract: The present invention provides a low molecular weight compound having EPO production-promoting action and/or hemoglobin production-promoting action. The present invention relates to a fused piperidine compound represented by the following general formula (1): (wherein, ring A represents a C10-14 aryl group or 5- to 10-membered heterocyclic group, X represents N—R7, a sulfur atom or an oxygen atom, R1, R2, R2?, R3 and R3? independently represent a hydrogen atom, C1-6 alkyl group or C3-6 cycloalkyl group, and R4, R5 and R6 independently represent a hydrogen atom or halogen atom), or a salt thereof, or a solvate thereof.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: A display screen of an onboard display device is disposed so that a speedometer is displayed in front of a driver of a vehicle. When a right-turn instruction is detected, a blinker is displayed and a rightward rear view image outside the vehicle is displayed on the right side of the display screen. When a left-turn instruction is detected, a blinker is displayed and a leftward rear view image outside the vehicle is displayed on the left side of the display screen. Displaying the image in different positions of the display screen according to the right or the left turn instruction facilitates an intuitive determination of a meaning of the image and makes it easier to drive the vehicle.

Abstract: To provide a novel JAK3 inhibitor that is useful as a preventive and/or therapeutic agent for rejection and graft versus host disease (GvHD) in organ transplantation, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, Sjögren syndrome, Behcet's disease, type I diabetes mellitus, autoimmune thyroiditis, idiopathic thrombocytopenic purpura, ulcerative colitis, Crohn's disease, asthma, allergic rhinitis, atopic dermatitis, contact dermatitis, urticaria, eczema, psoriasis, allergic conjunctivitis, uveitis, cancer, leukemia and the like. The pyridine-3-carboxyamide derivative represented by the general formula (1): or its salt or a solvate thereof.

Abstract: An onboard display device includes a display section attached to an instrument panel of a vehicle. The section has a second display area and a first display area. The second display area shows at least the speed as vehicle condition images indicating the conditions of the vehicle. The first display area shows a navigation image and other secondary images. The display section measures greater in width than in height with an aspect ratio of 7:3 or greater. The aspect ratio is the width/height ratio of a display area. The onboard display device allows for a visibility-improved simultaneous display of the secondary image, such as a navigation image, and the vehicle condition image, such as a speed display, which presents information on the conditions of the vehicle.

Abstract: In a condition detection and display system (100), an omnidirectional camera (1), internal condition sensors (3), external condition sensors (4), and others detect a condition of a vehicle and surroundings around the vehicle, image data which is a detection result obtained by the aforesaid members and contains an image of the vehicle is selected from an image database (6), and the selected image data is displayed on a liquid crystal panel (7) at a position close to a display of a speedometer.

Abstract: An onboard display device includes a display section attached to an instrument panel of a vehicle. The section has a second display area and a first display area. The second display area shows at least the speed as vehicle condition images indicating the conditions of the vehicle. The first display area shows a navigation image and other secondary images. The display section measures greater in width than in height with an aspect ratio of 7:3 or greater. The aspect ratio is the width/height ratio of a display area. The onboard display device allows for a visibility-improved simultaneous display of the secondary image, such as a navigation image, and the vehicle condition image, such as a speed display, which presents information on the conditions of the vehicle.

Abstract: Disclosed is a low-molecular-weight compound having an EPO production-promoting activity and/or a hemoglobin expression-enhancing activity. Specifically disclosed is an EPO production promoter and/or a hemoglobin expression enhancer comprising a 1-acyl-4-(phenoxy, benzyloxy or phenylamino)-1,2,3,4-tetrahydroquinoline derivative, more specifically a tetrahydroquinoline compound represented by the general formula (1); [wherein R1, R2, R2?, R3 and R3? independently represent a hydrogen atom, a C1-6 alkyl group, or the like; R4, R5, R6, R7, R8, R9 and R10 independently represent a hydrogen atom, a halogen atom, a C1-6 alkyl group, or the like; A represents N—R11 or an oxygen atom; R11 represents a hydrogen atom, a C1-6 alkyl group, or the like; and n represents an integer of 0 or 1], a salt of the tetrahydroquinoline compound, or a solvate of the tetrahydroquinoline compound or the salt.

Abstract: Facilitating viewer comparison of a plurality of medical images of at least one body part on a softcopy review workstation is described. First and second medical images are displayed such that the second medical image appears as a spatially registered underlay to the first medical image exposed through an aperture therein. The aperture comprises at least one edge that is viewer-manipulable in a back-and-forth manner so that the first and second medical images can be visually compared with minimal eye movement. For a temporal comparison embodiment, the first and second medical images comprise identical views of the same body part acquired at different times. For a cross-modality comparison embodiment, the first and second medical images are acquired substantially concurrently, or at different times, using different medical imaging modalities. For a bilateral comparison embodiment, the first and second images are corresponding views of two laterally corresponding body parts.